1. Home
  2. MRBK vs ELTX Comparison

MRBK vs ELTX Comparison

Compare MRBK & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Meridian Corporation

MRBK

Meridian Corporation

HOLD

Current Price

$20.17

Market Cap

222.3M

Sector

Finance

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$12.08

Market Cap

209.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRBK
ELTX
Founded
2004
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
222.3M
209.9M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
MRBK
ELTX
Price
$20.17
$12.08
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$20.00
$18.00
AVG Volume (30 Days)
119.3K
111.3K
Earning Date
04-28-2026
05-12-2026
Dividend Yield
2.77%
N/A
EPS Growth
30.34
39.29
EPS
1.89
N/A
Revenue
$6,316,000.00
$2,301,000.00
Revenue This Year
$25.40
N/A
Revenue Next Year
$8.15
N/A
P/E Ratio
$10.68
N/A
Revenue Growth
10.13
N/A
52 Week Low
$11.17
$4.70
52 Week High
$21.59
$14.93

Technical Indicators

Market Signals
Indicator
MRBK
ELTX
Relative Strength Index (RSI) 60.93 56.51
Support Level $18.32 $9.99
Resistance Level $20.86 $12.52
Average True Range (ATR) 0.54 0.91
MACD 0.03 0.16
Stochastic Oscillator 51.25 55.69

Price Performance

Historical Comparison
MRBK
ELTX

About MRBK Meridian Corporation

Meridian Corp is a bank holding company based in the United States. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal and business lending and deposit services. It operates in three reportable segments, including Bank, Wealth, and Mortgage. Meridian generates maximum revenue from the Bank segment, which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans. Geographically, it operates in Pennsylvania, New Jersey, and Delaware, as well as in the Central Maryland market and southwest Florida, U.S.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

Share on Social Networks: